Mayo, Hadar B.
HRN: 09-72-55 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/19/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
04/19/2023
04/26/2023
IV
1.5g
Q8H
Aspiration Pneumonia, Lacerated Wound, Post Auricular Area, R
Waiting Final Action
Indication: Empirical Escalation Type of Infection: PneumoniaSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes